Navigation Links
Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT
Date:9/12/2011

l and administrative2,5062,6869,1257,561Total operating expenses12,3819,35443,60724,919Loss from operations(10,995)(6,861)(35,374)(15,612)Interest and other income (expense), net312317138Loss before benefit from income tax(10,964)(6,838)(35,203)(15,574)Benefit from income tax---550Net loss

$

  (10,964)

$(6,838)

$(35,203)

$(15,024)Basic and diluted net loss per share

$(0.18)

$(0.13)

$(0.59)

$(0.31)Shares used to compute basic and   diluted net loss per share60,96851,77159,97348,344*  Includes share-based compensation as follows:Research and development

$

1,133

$

1,400

$

5,307

$

1,998General and administrative7134922,5111,192Total

$

1,846

$

1,892

$

7,818

$

3,190Reconciliation of Selected GAAP Measures to Non-GAAP Measures (1)(unaudited; in thousands, except per share data)Three Months EndedJune 30,20112010GAAP net loss$

(10,964)

$

(6,838)Adjustments:Research & development share-based compensation(2)1,1331,400General & administrative share-based compensation(2)7134921,8461,892Non-GAAP net loss$

(9,118)

$

(4,946)Non-GAAP net loss per share$

(0.15)

$

(0.10)(1)

This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our financial statements prepared in accordance with GAAP.(2)

All share-based compensation was excluded for the non-GAAP analysis.Reconciliation of Selected GAAP Measures to Non-GAAP Measures (1)(unaudited; in thousands, except per share data)Year Ended June 30,20112010GAAP net loss$

(35,203)

$

(15,024)Adjustments:Research & development share-based compensation(2)5,3071,998General & administrative share-based compen
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call
2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
3. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
4. Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011
5. Pharmacyclics to Announce Second Quarter Fiscal 2011 Results and Host a Conference Call on February 4, 2011
6. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
7. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
8. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
10. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
11. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  Intrexon Corporation (NYSE: XON ), ... fourth quarter and full year results for 2014.  ... , Acquired ActoGeniX, a European clinical stage ... therapeutics and other innovative products.  Its proprietary TopAct™ ... ( Lactococcus lactis ) to generate biologically-contained ActoBiotics™ ...
(Date:3/2/2015)... , March 2, 2015 BD (Becton, ... leading global medical technology company, today announced the acquisition ... -based medical technology company dedicated to improving the ... furthers BD,s position in helping address preventable medication errors ... CRISI entered into an exclusive partnership in June 2013 ...
(Date:3/2/2015)... 2015   Oriel STAT A MATRIX ... the most critical compliance and performance issues in ... manufacturers are experiencing an industry-transforming level of demand ... and global supply chains are negatively impacting product ... global regulators are increasing compliance requirements, scrutiny, and ...
Breaking Medicine Technology:Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24BD Acquires CRISI Medical Systems 2BD Acquires CRISI Medical Systems 3Oriel STAT A MATRIX Announces New Professional Certification Programs for Medical Device Regulatory and Quality Assurance Professionals 2Oriel STAT A MATRIX Announces New Professional Certification Programs for Medical Device Regulatory and Quality Assurance Professionals 3
... Israel, Nov. 15, 2011 InspireMD, Inc. (OTC ... focusing on the development and commercialization of its proprietary stent ... 10-Q for the three months ended September 30, 2011 with ... update on progress year-to-date: Year-to-Date Highlights ...
... to Quit" is a comprehensive quit-smoking program designed ... available exclusively at Walmart. Through the program, smokers ... QuitNet.com – including trained experts and a variety ... nicotine replacement therapy (NRT) to help curb cravings ...
Cached Medicine Technology:InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 2InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 3InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 4InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 5InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 6InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 7InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 8InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update 9New "Blueprint to Quit" Comprehensive Smoking Cessation Program Available for Smokers 2New "Blueprint to Quit" Comprehensive Smoking Cessation Program Available for Smokers 3New "Blueprint to Quit" Comprehensive Smoking Cessation Program Available for Smokers 4
(Date:3/2/2015)... (PRWEB) March 02, 2015 Today the Brain ... Awareness Month, a time to recognize and support the more ... , Each year BIAA leads the nation in observing ... the month of March. The theme for the 2015 to ... campaign provides a platform for educating the general public about ...
(Date:3/2/2015)... Market Publishers Ltd is extremely happy to ... Industry Analysts Inc and recently added to its catalogue. ... Through 2018, the global radiation therapy equipment market is ... report suggests a holistic analysis of the situation in ... as covers the top market trends. The publication uncovers ...
(Date:3/2/2015)... 2015 Tyrone Christopher, Co-founder of Soft ... for the model agency industry, have launched Softcandy.sexy, an ... Passion Fruit, Pink Grapefruit, Pomegranate, and or Vanilla flavored ... , At a cost of alienating a few potential ... by announcing the brands commitment and support of a ...
(Date:3/2/2015)... March 02, 2015 After a rigorous ... customer service, pricing and long-term strategy, Blood Centers of ... of choice for member centers’ testing needs. , BCA, ... represents more than 30 percent of the U.S. blood ... , “BCA is committed to drive cost savings to ...
(Date:3/2/2015)... Mountain View, CA (PRWEB) March 02, 2015 ... announced today that it has officially launched a ... Bo Gustafsson, head of product development for BNatrl, ... developed through feedback from Olympic and other world-class ... I'm excited to use this pure whole food ...
Breaking Medicine News(10 mins):Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Bnatrl Launches Multivitamin Supplement for Runners 2
... Jenifer Goodwin HealthDay Reporter , WEDNESDAY, Aug. 31 ... uses a virus to infect and destroy tumor cells without ... The small, Phase 1 trial involved 23 patients with ... had exhausted other treatment options. Each received an intravenous ...
... HealthDay Reporter , WEDNESDAY, Aug. 31 (HealthDay News) ... their calories from sweetened drinks, a new report indicates. ... sugar in one,s diet, and for many, sugar-sweetened drinks are ... to obesity and related illnesses such as diabetes, experts say. ...
... August 31, 2011 - Scientists at The Scripps Research ... a direct role in the development and spread of cancerous ... the disease and points toward novel strategies for treating early-stage ... issue of the American Journal of Pathology . ...
... Aug. 31 (HealthDay News) -- A new study says physical ... for patients with melanoma, the most dangerous form of skin ... found that young melanoma patients in poor health had worse ... study of 101 patients treated for stage III melanoma showed ...
... WEDNESDAY, Aug. 31 (HealthDay News) -- Smoking causes more arterial ... Researchers used ultrasound to assess the carotid arteries (neck ... and 1,694 men in Finland, Sweden, the Netherlands, France and ... was associated with thickening of the arterial walls (atherosclerosis) in ...
... , WEDNESDAY, Aug. 31 (HealthDay News) --,Hospitalized ... but show no signs of illness are still at ... finds. The germ -- methicillin-resistant staphylococcus aureus (MRSA) ... year in the United States. Johns Hopkins Children,s ...
Cached Medicine News:Health News:Trial of Cancer-Fighting Virus Shows Promise 2Health News:Trial of Cancer-Fighting Virus Shows Promise 3Health News:Americans Getting Too Many Calories From Sugary Drinks: CDC 2Health News:Americans Getting Too Many Calories From Sugary Drinks: CDC 3Health News:Americans Getting Too Many Calories From Sugary Drinks: CDC 4Health News:Scripps Research scientists reveal how white blood cell promotes growth and spread of cancer 2Health News:Scripps Research scientists reveal how white blood cell promotes growth and spread of cancer 3Health News:Kids Carrying MRSA Germ Prone to Serious Infection: Study 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: